INBRAIN Neuroelectronics

INBRAIN Neuroelectronics

Private
BarcelonaHealthcare & Life Scienceshttps://www.inbrain-neuroelectronics.com

Last Round

Grant

May 6, 2025

Total Funding Raised

$72.22M

Momentum Score

25 /100

Company Overview

INBRAIN Neuroelectronics is a medical technology company that develops graphene-based, AI-powered brain-computer interface (BCI) therapies for neurological conditions such as Parkinson's and epilepsy.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Advanced Materials, Precision Medicine, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Government Contracts

AI Layer

Application

Keywords

brain-computer interfaceBCIgraphene bioelectronicsneurotechneuromodulationbrain implantneural interfaceclosed-loop neuromodulationadaptive neurostimulationbrain decodingpersonalized neurostimulationAI medical platformParkinson's disease therapyepilepsy therapymedical deviceperipheral nerve applications

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

INBRAIN Neuroelectronics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

INBRAIN Neuroelectronics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantMay 6, 2025
Series BOct 29, 2024
Series AMar 30, 2021
SeedJun 29, 2020

Key People

Founding team and executive leadership

Jose Antonio Garrido

Founder And Chief Scientific Officer

Founding Team

Carolina Aguilar

Chief Executive Officer Co-Founder

Founding Team

Jurriaan Bakker

Chief Technology Officer

Executive Team

INBRAIN Neuroelectronics Investors

Notable investors and investment history

InvestorRounds
Asabys PartnersSeries B, Series A, Seed
Alta Life SciencesSeries A, Seed
ICF Venture Tech IISeries A
AvançsaSeries B
Ysios CapitalSeed
Fond-ICO Next TechSeries B
imec.xpandSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Collaboration to advance neuroelectronic therapies.

  • Dec 9, 2025

    Scott Huennekens appointed Chairman of the Board of Directors.

INBRAIN Neuroelectronics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

INBRAIN Neuroelectronics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about INBRAIN Neuroelectronics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBarcelona
Employee Range108
Year Founded2019
Last FundingMay 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.